IAP Antagonists Induce Autoubiquitination of c-IAPs, NF-κB Activation, and TNFα-Dependent Apoptosis

Cell - Tập 131 Số 4 - Trang 669-681 - 2007
Eugene Varfolomeev1, John W. Blankenship1, Sarah M. Wayson1, Anna Fedorova1, Nobuhiko Kayagaki2, Parie Garg2, Kerry Zobel1, Jasmin N. Dynek1, Linda O. Elliott3, Heidi J.A. Wallweber1, John A. Flygare3, Wayne J. Fairbrother1, Kurt Deshayes1, Vishva M. Dixit2, Domagoj Vucic1
1Department of Protein Engineering, Genentech, Inc., South San Francisco, CA 94080, USA
2Department of Physiological Chemistry, Genentech, Inc., South San Francisco, CA 94080, USA
3Department of Medicinal Chemistry, Genentech, Inc., South San Francisco, CA 94080, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Annunziata, 2007, Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma, Cancer Cell, 12, 115, 10.1016/j.ccr.2007.07.004

Ashkenazi, 1999, Apoptosis control by death and decoy receptors, Curr. Opin. Cell Biol., 11, 255, 10.1016/S0955-0674(99)80034-9

Budihardjo, 1999, Biochemical pathways of caspase activation during apoptosis, Annu. Rev. Cell Dev. Biol., 15, 269, 10.1146/annurev.cellbio.15.1.269

Chen, 2002, TNF-R1 signaling: a beautiful pathway, Science, 296, 1634, 10.1126/science.1071924

Chen, 2005, Ubiquitin signalling in the NF-kappaB pathway, Nat. Cell Biol., 7, 758, 10.1038/ncb0805-758

Du, 2000, Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition, Cell, 102, 33, 10.1016/S0092-8674(00)00008-8

Franken, 2006, Clonogenic assay of cells in vitro, Nat Protoc, 1, 2315, 10.1038/nprot.2006.339

Gao, 2007, A dimeric Smac/diablo peptide directly relieves caspase-3 inhibition by XIAP: Dynamic and cooperative regulation of XIAP by Smac/diablo, J. Biol. Chem., 10.1074/jbc.M705258200

Grech, 2004, TRAF2 differentially regulates the canonical and noncanonical pathways of NF-κB activation in mature B cells, Immunity, 21, 629, 10.1016/j.immuni.2004.09.011

Hayden, 2004, Signaling to NF-kappaB, Genes Dev., 18, 2195, 10.1101/gad.1228704

Hofmann, 1997, The CARD domain: a new apoptotic signalling motif, Trends Biochem. Sci., 22, 155, 10.1016/S0968-0004(97)01043-8

Hunter, 2007, The inhibitors of apoptosis (IAPs) as cancer targets, Apoptosis, 12, 1543, 10.1007/s10495-007-0087-3

Johnston, 1981, Dye uptake method for assay of interferon activity, Methods Enzymol., 78, 394, 10.1016/0076-6879(81)78147-3

Kaufmann, 2003, Alterations in the apoptotic machinery and their potential role in anticancer drug resistance, Oncogene, 22, 7414, 10.1038/sj.onc.1206945

Keats, 2007, Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma, Cancer Cell, 12, 131, 10.1016/j.ccr.2007.07.003

Li, 2004, A small molecule Smac mimic potentiates TRAIL- and TNFα-mediated cell death, Science, 305, 1471, 10.1126/science.1098231

Li, 2002, TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2, Nature, 416, 345, 10.1038/416345a

Liston, 2003, The inhibitors of apoptosis: there is more to life than Bcl2, Oncogene, 22, 8568, 10.1038/sj.onc.1207101

Liu, 2000, Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain, Nature, 408, 1004, 10.1038/35050006

Micheau, 2003, Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes, Cell, 114, 181, 10.1016/S0092-8674(03)00521-X

Miller, 1999, An exegesis of IAPs: salvation and surprises from BIR motifs, Trends Cell Biol., 9, 323, 10.1016/S0962-8924(99)01609-8

Oost, 2004, Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer, J. Med. Chem., 47, 4417, 10.1021/jm040037k

Reed, 2003, Apoptosis-targeted therapies for cancer, Cancer Cell, 3, 17, 10.1016/S1535-6108(02)00241-6

Rothe, 1995, The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins, Cell, 83, 1243, 10.1016/0092-8674(95)90149-3

Rothe, 1994, A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor, Cell, 78, 681, 10.1016/0092-8674(94)90532-0

Salvesen, 2004, Caspase activation - stepping on the gas or releasing the brakes? Lessons from humans and flies, Oncogene, 23, 2774, 10.1038/sj.onc.1207522

Salvesen, 2002, IAP proteins: blocking the road to death's door, Nat. Rev. Mol. Cell Biol., 3, 401, 10.1038/nrm830

Samuel, 2006, Distinct BIR domains of cIAP1 mediate binding to and ubiquitination of tumor necrosis factor receptor-associated factor 2 and second mitochondrial activator of caspases, J. Biol. Chem., 281, 1080, 10.1074/jbc.M509381200

Scheidereit, 2006, IκB kinase complexes: gateways to NF-κB activation and transcription, Oncogene, 25, 6685, 10.1038/sj.onc.1209934

Senftleben, 2001, Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway, Science, 293, 1495, 10.1126/science.1062677

Sharma, 2006, Development of peptidomimetics targeting IAPs, International Journal of Peptide Research and Therapeutics, 12, 21, 10.1007/s10989-005-9003-2

Sharp, 2005, Selective knockdown of the long variant of cellular FLICE inhibitory protein augments death receptor-mediated caspase-8 activation and apoptosis, J. Biol. Chem., 280, 19401, 10.1074/jbc.M413962200

Shu, 1996, The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex, Proc. Natl. Acad. Sci. USA, 93, 13973, 10.1073/pnas.93.24.13973

Steller, 1995, Mechanisms and genes of cellular suicide, Science, 267, 1445, 10.1126/science.7878463

Sun, 2004, Structure-based design of potent, conformationally constrained Smac mimetics, J. Am. Chem. Soc., 126, 16686, 10.1021/ja047438+

Thompson, 1995, Apoptosis in the pathogenesis and treatment of disease, Science, 267, 1456, 10.1126/science.7878464

Varfolomeev, 2005, Molecular determinants of kinase pathway activation by Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand, J. Biol. Chem., 280, 40599, 10.1074/jbc.M509560200

Varfolomeev, 2006, The inhibitor of apoptosis protein fusion c-IAP2.MALT1 stimulates NF-κB activation independently of TRAF1 AND TRAF2, J. Biol. Chem., 281, 29022, 10.1074/jbc.M605116200

Vaux, 2005, IAPs, RINGs and ubiquitylation, Nat. Rev. Mol. Cell Biol., 6, 287, 10.1038/nrm1621

Verhagen, 2000, Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins, Cell, 102, 43, 10.1016/S0092-8674(00)00009-X

Vucic, 2002, SMAC Negatively Regulates the Anti-apoptotic Activity of Melanoma Inhibitor of Apoptosis (ML-IAP), J. Biol. Chem., 277, 12275, 10.1074/jbc.M112045200

Vucic, 2005, Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP, Biochem. J., 385, 11, 10.1042/BJ20041108

Vucic, 2000, ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas, Curr. Biol., 10, 1359, 10.1016/S0960-9822(00)00781-8

Wang, 1998, NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation, Science, 281, 1680, 10.1126/science.281.5383.1680

Wertz, 2004, De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling, Nature, 430, 694, 10.1038/nature02794

Wu, 2000, Structural basis of IAP recognition by Smac/DIABLO, Nature, 408, 1008, 10.1038/35050012

Xiao, 2001, NF-κB-inducing kinase regulates the processing of NF-κB2 p100, Mol. Cell, 7, 401, 10.1016/S1097-2765(01)00187-3

Yang, 2004, Smac/DIABLO selectively reduces the levels of c-IAP1 and c-IAP2 but not that of XIAP and livin in HeLa cells, J. Biol. Chem., 279, 16963, 10.1074/jbc.M401253200

Yang, 2000, Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli, Science, 288, 874, 10.1126/science.288.5467.874

Zender, 2006, Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach, Cell, 125, 1253, 10.1016/j.cell.2006.05.030

Zobel, 2006, Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs, ACS Chem Biol, 1, 525, 10.1021/cb600276q